suPAR is a Risk Marker for Kidney Disease in Acute Medical Patients

Fri Jun 12 2020

New study showing that elevated suPAR is an independent risk marker for incident chronic and acute kidney disease in acute medical patients, is published in Frontiers in Cell and Developmental Biology by Iversen E. et al.

The aim of the study was to determine whether elevated plasma suPAR level measured at hospital admission is associated with incident kidney disease in patients presenting to the emergency department.

More than 25.000 acute medical patients were followed for 4 years for development of kidney disease.

Results shows a 57% higher risk of developing a chronic kidney condition and 151% higher risk of developing an acute kidney condition with each doubling in suPAR level at hospital admission.

Thus, elevated suPAR level in acute medical patients is independently associated with incident chronic and acute kidney conditions, as well as all-cause mortality.

This highlights the potential for using suPAR in risk classification models to identify high-risk patients, who could benefit from early clinical interventions.

If patients are classified based of the risk of developing kidney disease, then closer monitoring and early interventions in high risk patients may slow kidney disease progression and avoid complications related to renal dysfunction.

Read the article here

+800

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates